SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014

por Garcia-Carbonero, R., JImenez-Fonseca, P., Teulé, A., Barriuso, J., Sevilla, I.
Publicado 2014

SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view

por Spada, F., Pellicori, S., Zampino, G., Funicelli, L., Gervaso, L., Laffi, A., Rubino, M., Garcia-Carbonero, R., Fazio, N.
Publicado 2020

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)

por González-Flores, E., Serrano, R., Sevilla, I., Viúdez, A., Barriuso, J., Benavent, M., Capdevila, J., Jimenez-Fonseca, P., López, C., Garcia-Carbonero, R.
Publicado 2018

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer

por Sastre, J., Argilés, G., Benavides, M., Feliú, J., García-Alfonso, P., García-Carbonero, R., Grávalos, C., Guillén-Ponce, C., Martínez-Villacampa, M., Pericay, C.
Publicado 2014

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015

por Aranda, E., Aparicio, J., Alonso, V., Garcia-Albeniz, X., Garcia-Alfonso, P., Salazar, R., Valladares, M., Vera, R., Vieitez, J. M., Garcia-Carbonero, R.
Publicado 2015

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: r...

por Longo-Muñoz, F., Argiles, G., Tabernero, J., Cervantes, A., Gravalos, C., Pericay, C., Gil-Calle, S., Mizuguchi, H., Carrato-Mena, A., Limón, M. L., Garcia-Carbonero , R.
Publicado 2016

SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

por Gómez-España, Mª A., Montes, A. F., Garcia-Carbonero, R., Mercadé, T. M., Maurel, J., Martín, A. M., Pazo-Cid, R., Vera, R., Carrato, A., Feliu, J.
Publicado 2021

Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of...

por García-Alfonso, P., García-Carbonero, R., García-Foncillas, J., Pérez-Segura, P., Salazar, R., Vera, R., Ramón y Cajal, S., Hernández-Losa, J., Landolfi, S., Musulén, E., Cuatrecasas, M., Navarro, S.
Publicado 2020

Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer

por Siena, S, Sartore-Bianchi, A, Garcia-Carbonero, R, Karthaus, M, Smith, D, Tabernero, J, Van Cutsem, E, Guan, X, Boedigheimer, M, Ang, A, Twomey, B, Bach, B A, Jung, A S, Bardelli, A
Publicado 2018

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas

por Garcia-Carbonero, R., Matute Teresa, F., Mercader-Cidoncha, E., Mitjavila-Casanovas, M., Robledo, M., Tena, I., Alvarez-Escola, C., Arístegui, M., Bella-Cueto, M. R., Ferrer-Albiach, C., Hanzu, F. A.
Publicado 2021

Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metast...

por Obermannová, R., Van Cutsem, E., Yoshino, T., Bodoky, G., Prausová, J., Garcia-Carbonero, R., Ciuleanu, T., Garcia Alfonso, P., Portnoy, D., Cohn, A., Yamazaki, K., Clingan, P., Lonardi, S., Kim, T. W., Yang, L., Nasroulah, F., Tabernero, J.
Publicado 2016

Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study

por Tabernero, J, Hozak, R R, Yoshino, T, Cohn, A L, Obermannova, R, Bodoky, G, Garcia-Carbonero, R, Ciuleanu, T -E, Portnoy, D C, Prausová, J, Muro, K, Siegel, R W, Konrad, R J, Ouyang, H, Melemed, S A, Ferry, D, Nasroulah, F, Van Cutsem, E
Publicado 2018

Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM)

por Elez, E., Ayala, F., Felip, E., García Campelo, R., García Carbonero, R., García Donás, J., González del Alba, A., González Flores, E., Hidalgo, J., Isla, D., Majem, M., Rodríguez Lescure, Á., Safont, M.J., Santaballa, A., Villacampa, G., Vera, R., Garrido, P.
Publicado 2021

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE—...

por Yoshino, T, Portnoy, D C, Obermannová, R, Bodoky, G, Prausová, J, Garcia-Carbonero, R, Ciuleanu, T, García-Alfonso, P, Cohn, A L, Van Cutsem, E, Yamazaki, K, Lonardi, S, Muro, K, Kim, T W, Yamaguchi, K, Grothey, A, O’Connor, J, Taieb, J, Wijayawardana, S R, Hozak, R R, Nasroulah, F, Tabernero, J
Publicado 2019

Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin

por Capdevila, J., Hernando, J., Teule, A., Lopez, C., Garcia-Carbonero, R., Benavent, M., Custodio, A., Garcia-Alvarez, A., Cubillo, A., Alonso, V., Carmona-Bayonas, A., Alonso-Gordoa, T., Crespo, G., Jimenez-Fonseca, P., Blanco, M., Viudez, A., La Casta, A., Sevilla, I., Segura, A., Llanos, M., Landolfi, S., Nuciforo, P., Manzano, J. L.
Publicado 2023

Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

por Borrero-Palacios, A., Cebrián, A., Gómez del Pulgar, M. T., García-Carbonero, R., Garcia-Alfonso, P., Aranda, E., Elez, E., López-López, R., Cervantes, A., Valladares, M., Nadal, C., Viéitez, J. M., Guillén-Ponce, C., Rodríguez, J., Hernández, I., García, J. L., Vega-Bravo, R., Puime-Otin, A., Martínez-Useros, J., Del Puerto-Nevado, L., Rincón, R., Rodríguez-Remírez, M., Rojo, F., García-Foncillas, J.
Publicado 2019

Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

por Borrero-Palacios, A., Cebrián, A., Gómez del Pulgar, M. T., García-Carbonero, R., Garcia-Alfonso, P., Aranda, E., Elez, E., López-López, R., Cervantes, A., Valladares, M., Nadal, C., Viéitez, J. M., Guillén-Ponce, C., Rodríguez, J., Hernández, I., García, J. L., Vega-Bravo, R., Puime-Otin, A., Martínez-Useros, J., Del Puerto-Nevado, L., Rincón, R., Rodríguez-Remírez, M., Rojo, F., García-Foncillas, J.
Publicado 2019

Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials

por Yoshino, T., Cleary, J. M., Van Cutsem, E., Mayer, R. J., Ohtsu, A., Shinozaki, E., Falcone, A., Yamazaki, K., Nishina, T., Garcia-Carbonero, R., Komatsu, Y., Baba, H., Argilés, G., Tsuji, A., Sobrero, A., Yamaguchi, K., Peeters, M., Muro, K., Zaniboni, A., Sugimoto, N., Shimada, Y., Tsuji, Y., Hochster, H. S., Moriwaki, T., Tran, B., Esaki, T., Hamada, C., Tanase, T., Benedetti, F., Makris, L., Yamashita, F., Lenz, H.-J.
Publicado 2020